Epitope mapping by solution NMR spectroscopy

Journal of Molecular Recognition

Volumn 28, Issue 6, 2015, Pages 393-400

  Bardelli, M ^a   Livoti, E ^a   Simonelli, L ^a   Pedotti, M ^a   Moraes, A ^b   Valente, A P ^b   Varani, L ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

antibodies; epitope mapping; NMR

Indexed keywords

ANTIBODY; EPITOPE; SOLUTION AND SOLUBILITY;

ALLOSTERISM; CHEMISTRY; EPITOPE MAPPING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; SOLUTION AND SOLUBILITY;

ALLOSTERIC REGULATION; ANTIBODIES; EPITOPE MAPPING; EPITOPES; MAGNETIC RESONANCE SPECTROSCOPY; SOLUTIONS;

EID: 84928166101     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.2454     Document Type: Article

References (43)

1. Bain AD,. 2003. Chemical exchange in NMR. Progr. Nucl. Magn. Reson. 43: 63-103.
2. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS, Whitlow M,. 1988. Single-chain antigen-binding proteins. Science 242 (4877): 423-426.
3. Blech M, Peter D, Fischer P, Bauer MM, Hafner M, Zeeb M, Nar H,. 2013. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1beta. J. Mol. Biol. 425 (1): 94-111.
4. Blech M, Seeliger D, Kistler B, Bauer MM, Hafner M, Horer S, Zeeb M, Nar H, Park JE,. 2012. Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications. Biochem. J. 447 (2): 205-215.
5. Clore GM, Gronenborn AM,. 1991. Structures of larger proteins in solution: three- and four-dimensional heteronuclear NMR spectroscopy. Science 252 (5011): 1390-1399.
6. Clore GM, Gronenborn AM,. 1994. Structures of larger proteins, protein-ligand and protein-DNA complexes by multi-dimensional heteronuclear NMR. Prog. Biophys. Mol. Biol. 62 (2): 153-184.
7. Corti D, Lanzavecchia A,. 2013. Broadly neutralizing antiviral antibodies. Annu Rev Immunol. 31.
8. de Vries SJ, van Dijk M, Bonvin AM,. 2010. The HADDOCK web server for data-driven biomolecular docking. Nat. Protoc. 5 (5): 883-897.
9. de Vries SJ, van Dijk AD, Krzeminski M, van Dijk M, Thureau A, Hsu V, Wassenaar T, Bonvin AM,. 2007. HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69 (4): 726-733.
10. Dominguez C, Boelens R, Bonvin AM,. 2003. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125 (7): 1731-1737.
11. Frueh DP,. 2014. Practical aspects of NMR signal assignment in larger and challenging proteins. Prog. Nucl. Magn. Reson. Spectrosc. 78C: 47-75.
12. Grinstead JS, Schuman JT, Campbell AP,. 2003. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study. Biochemistry 42 (48): 14293-14305.
13. Ikura M, Kay LE, Bax A,. 1990. A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin. Biochemistry 29 (19): 4659-4667.
14. Jang R, Gao X, Li M,. 2011. Towards fully automated structure-based NMR resonance assignment of (1)(5)N-labeled proteins from automatically picked peaks. J. Comput. Biol. 18 (3): 347-363.
15. Jung Y-S, Zweckstetter M,. 2004. Mars -robust automatic backbone assignment of proteins. J. Biomol. NMR 30: 11-23.
16. Kay LE,. 2005. NMR studies of protein structure and dynamics. J. Magn. Reson. 173 (2): 193-207.
17. Kay LE,. 2011a. NMR studies of protein structure and dynamics-a look backwards and forwards. J. Magn. Reson. 213 (2): 492-494.
18. Kay LE,. 2011b. NMR studies of protein structure and dynamics. 2005. J. Magn. Reson. 213 (2): 477-491.
19. Leopold MF, Urbauer JL, Wand AJ,. 1994. Resonance assignment strategies for the analysis of NMR spectra of proteins. Mol. Biotechnol. 2 (1): 61-93.
20. Mage MG,. 1980. Preparation of Fab fragments from IgGs of different animal species. Methods Enzymol. 70 (A): 142-150.
21. Marasco WA, Sui J,. 2007. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat. Biotechnol. 25 (12): 1421-1434.
22. Michel E, Skrisovska L, Wuthrich K, Allain FH,. 2013. Amino acid-selective segmental isotope labeling of multidomain proteins for structural biology. Chembiochem 14 (4): 457-466.
23. Morgan WD, Lock MJ, Frenkiel TA, Grainger M, Holder AA,. 2004. Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR. Mol. Biochem. Parasitol. 138 (1): 29-36.
24. Mueller GA, Smith AM, Chapman MD, Rule GS, Benjamin DC,. 2001. Hydrogen exchange nuclear magnetic resonance spectroscopy mapping of antibody epitopes on the house dust mite allergen Der p 2. J. Biol. Chem. 276 (12): 9359-9365.
25. Pedotti M, Simonelli L, Livoti E, Varani L,. 2011. Computational docking of antibody-antigen complexes, opportunities and pitfalls illustrated by influenza hemagglutinin. Int. J. Mol. Sci. 12 (1): 226-251.
26. Razzera G, Gadermaier G, de Paula V, Almeida MS, Egger M, Jahn-Schmid B, Almeida FC, Ferreira F, Valente AP,. 2010. Mapping the interactions between a major pollen allergen and human IgE antibodies. Structure 18 (8): 1011-1021.
27. Ryabov Y, Clore GM, Schwieters CD,. 2010. Direct use of 15N relaxation rates as experimental restraints on molecular shape and orientation for docking of protein-protein complexes. J. Am. Chem. Soc. 132 (17): 5987-5989.
28. Sandercock CG, Storz U,. 2012. Antibody specification beyond the target: claiming a later-generation therapeutic antibody by its target epitope. Nat. Biotechnol. 30 (7): 615-618.
29. Simonelli L, Beltramello M, Yudina Z, Macagno A, Calzolai L, Varani L,. 2010. Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking. J. Mol. Biol. 396 (5): 1491-1507.
30. Simonelli L, Pedotti M, Beltramello M, Livoti E, Calzolai L, Sallusto F, Lanzavecchia A, Varani L,. 2013. Rational engineering of a human anti-dengue antibody through experimentally validated computational docking. PLoS One 8 (2): e55561.
31. Skrisovska L, Allain FH,. 2008. Improved segmental isotope labeling methods for the NMR study of multidomain or large proteins: application to the RRMs of Npl3p and hnRNP L. J. Mol. Biol. 375 (1): 151-164.
32. Skrisovska L, Schubert M, Allain FH,. 2010. Recent advances in segmental isotope labeling of proteins: NMR applications to large proteins and glycoproteins. J. Biomol. NMR 46 (1): 51-65.
33. Takahashi H, Nakanishi T, Kami K, Arata Y, Shimada I,. 2000. A novel NMR method for determining the interfaces of large protein-protein complexes. Nat. Struct. Biol. 7 (3): 220-223.
34. Tugarinov V, Zvi A, Levy R, Hayek Y, Matsushita S, Anglister J,. 2000. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding. Structure 8 (4): 385-395.
35. Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, Livny M, Mading S, Maziuk D, Miller Z, Nakatani E, Schulte CF, Tolmie DE, Kent Wenger R, Yao H, Markley JL,. 2008. BioMagResBank. Nucleic Acids Res. 36 (Database issue): D402-408.
36. Varani L, Bankovich AJ, Liu CW, Colf LA, Jones LL, Kranz DM, Puglisi JD, Garcia KC,. 2007. Solution mapping of T cell receptor docking footprints on peptide-MHC. Proc. Natl. Acad. Sci. U. S. A. 104 (32): 13080-13085.
37. Wagner G,. 1993. Prospects for NMR of large proteins. J. Biomol. NMR 3 (4): 375-385.
38. Walker LM, Bowley DR, Burton DR,. 2009. Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library. J. Mol. Biol. 389 (2): 365-375.
39. Wider G, Wuthrich K,. 1999. NMR spectroscopy of large molecules and multimolecular assemblies in solution. Curr. Opin. Struct. Biol. 9 (5): 594-601.
40. Wilkinson IC, Hall CJ, Veverka V, Shi JY, Muskett FW, Stephens PE, Taylor RJ, Henry AJ, Carr MD,. 2009. High resolution NMR-based model for the structure of a scFv-IL-1 complex: potential for NMR as a key tool in therapeutic antibody design and development. J Biol Chem 284 (46): 31928-31935.
41. Williamson MP,. 2013. Using chemical shift perturbation to characterise ligand binding. Prog. Nucl. Magn. Reson. Spectrosc. 73: 1-16.
42. Williamson RA, Carr MD, Frenkiel TA, Feeney J, Freedman RB,. 1997. Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry 36 (45): 13882-13889.
43. Zuiderweg ER,. 2002. Mapping protein-protein interactions in solution by NMR spectroscopy. Biochemistry 41 (1): 1-7.